Abt Nicholas B, Lehar Mohamed, Guajardo Carolina Trevino, Penninger Richard T, Ward Bryan K, Pearl Monica S, Carey John P
*Department of Otolaryngology-Head and Neck Surgery †Department of Radiology-Neuroradiology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Otol Neurotol. 2016 Apr;37(4):403-7. doi: 10.1097/MAO.0000000000000974.
Whether the round window membrane (RWM) is permeable to iodine-based contrast agents (IBCA) is unknown; therefore, our goal was to determine if IBCAs could diffuse through the RWM using CT volume acquisition imaging.
Imaging of hydrops in the living human ear has attracted recent interest. Intratympanic (IT) injection has shown gadolinium's ability to diffuse through the RWM, enhancing the perilymphatic space.
Four unfixed human cadaver temporal bones underwent intratympanic IBCA injection using three sequentially studied methods. The first method was direct IT injection. The second method used direct RWM visualization via tympanomeatal flap for IBCA-soaked absorbable gelatin pledget placement. In the third method, the middle ear was filled with contrast after flap elevation. Volume acquisition CT images were obtained immediately postexposure, and at 1-, 6-, and 24-hour intervals. Postprocessing was accomplished using color ramping and subtraction imaging.
After the third method, positive RWM and perilymphatic enhancement were observed with endolymph sparing. Gray scale and color ramp multiplanar reconstructions displayed increased signal within the cochlea compared with precontrast imaging. The cochlea was measured for attenuation differences compared with pure water, revealing a preinjection average of -1,103 HU and a postinjection average of 338 HU. Subtraction imaging shows enhancement remaining within the cochlear space, Eustachian tube, middle ear epithelial lining, and mastoid.
Iohexol iodine contrast is able to diffuse across the RWM. Volume acquisition CT imaging was able to detect perilymphatic enhancement at 0.5-mm slice thickness. The clinical application of IBCA IT injection seems promising but requires further safety studies.
圆窗膜(RWM)是否能透过碘基造影剂(IBCA)尚不清楚;因此,我们的目标是使用CT容积采集成像来确定IBCA是否能扩散通过圆窗膜。
活体人耳积水的成像近来引起了人们的关注。鼓室内(IT)注射已显示钆能够扩散通过圆窗膜,增强外淋巴间隙。
使用三种依次研究的方法对四块未固定的人尸体颞骨进行鼓室内IBCA注射。第一种方法是直接鼓室内注射。第二种方法是通过鼓膜耳道皮瓣直接观察圆窗膜,放置浸泡有IBCA的可吸收明胶棉片。在第三种方法中,皮瓣掀起后中耳充满造影剂。在暴露后立即以及在1小时、6小时和24小时间隔时获取容积采集CT图像。使用颜色渐变和减影成像进行后处理。
在第三种方法后,观察到圆窗膜和外淋巴增强,内淋巴未受影响。与造影前成像相比,灰度和颜色渐变多平面重建显示耳蜗内信号增加。测量耳蜗与纯水相比的衰减差异,显示注射前平均为-1103HU,注射后平均为338HU。减影成像显示耳蜗间隙、咽鼓管、中耳上皮衬里和乳突内仍有增强。
碘海醇碘造影剂能够扩散穿过圆窗膜。容积采集CT成像能够在0.5毫米切片厚度下检测到外淋巴增强。IBCA鼓室内注射的临床应用似乎很有前景,但需要进一步的安全性研究。